Privi Fine Sciences Private Limited

Privi Fine Sciences Private Limited - chemicals and materials in Thane, Maharashtra, India. FY 2026 financials and compliance.
CIN U24110MH2021PTC358857 Incorporated 13 April 2021 ROC Mumbai HQ Thane, Maharashtra, India
Active Private Limited Company chemicals and materials
Data last updated
Revenue · FY 2025
₹52.15 Cr
▲ 546.00% YoY
EBITDA · FY 2025
*****
▼ 1210.00% YoY
Net profit · FY 2025
*****
▼ 1444.00% YoY
Authorised capital
₹240 Cr
Registered with MCA
Paid-up capital
₹233.83 Cr
Issued & subscribed
Open charges
₹100 Cr
Secured borrowings
Company age
5 yrs
Est. 2021
Last financials
Mar 2025
Balance sheet date

About Privi Fine Sciences Private Limited

Data last updated: 16 February 2026

Privi Fine Sciences Private Limited is a private limited company based in Thane, Maharashtra, India. It specialises in industrial chemicals, a part of the broader chemicals and materials sector. Incorporated on 13 April 2021, the company has been in operation for over 5 years.

Registered with ROC Mumbai under CIN U24110MH2021PTC358857.

Capital: an authorised share capital of ₹240 Cr and a paid-up capital of ₹233.83 Cr. It is led by directors including Snehal Mahesh Babani and Sanjeev Gajanan Patil.

Last AGM: 15 July 2025. Financial statements filed for year ended 31 March 2025. Office: Ground Floor Privi House A – 71 Ttc, Thane Belapur Road Kopar Khairane Navi Mumbai, Maharashtra, India – 400710.

As per the financials filed for FY 2025, the company reported a revenue of ₹52.15 Cr, reflecting significant growth compared to the previous year.

As per MCA filings, the company has open charges of ₹100 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies.

Company Details of Privi Fine Sciences Private Limited
CIN U24110MH2021PTC358857
Registration Number 358857
Incorporation Date 13 April 2021
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 15 July 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Key People
Snehal Mahesh Babani Managing Director Sanjeev Gajanan Patil Whole-Time Director Arun Anant Newalkar Cfo
Contact Details
  • Email
    *****@*****.com
  • Telephone
    +91-****-******
  • Website
    **************
  • Social Media
    **************
  • Registered Address
    Ground Floor Privi House A – 71 Ttc, Thane Belapur Road Kopar Khairane Navi Mumbai, Maharashtra, India – 400710
  • Industry
    Chemicals and Materials, Industrial Chemicals
Company report
Privi Fine Sciences Private Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Privi Fine Sciences Private Limited report

Financials, compliance, directors, charges, ownership and filings for Privi Fine Sciences Private Limited in one report.

10-year financials Directors & ownership Charges & compliance

Auditor Details of Privi Fine Sciences Private Limited

Privi Fine Sciences Private Limited is audited by E.E.Sitabkhan & Co for the financial year 2023. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.

Name Status Appointment Date Cessation Date
E.E.Sitabkhan & Co blur-value blur-value blur-value

Board of Directors of Privi Fine Sciences Private Limited

Privi Fine Sciences Private Limited is currently managed by 7 directors, with 3 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Snehal Mahesh Babani
Also directs: Babani Buildcon Llp, Snejyo Agro Llp, Vivira Investment And Trading Private Limited and 1 more
Managing Director 13 Apr 2021 5 Years 2 Months Current
Sanjeev Gajanan Patil
Also directs: Mm Speciality Chemicals Private Limited, Moneymart Securities Private Limited, Mm Infra & Leasing Private Limited
Whole-Time Director 01 Apr 2024 2 Years 3 Months Current
Arun Anant Newalkar
Also directs: Mm Speciality Chemicals Private Limited, Moneymart Securities Private Limited, Mm Infra & Leasing Private Limited and 2 more
Cfo 01 Apr 2024 2 Years 3 Months Current
Jyoti Mahesh Babani
Also directs: Prigiv Specialties Private Limited, Babani Buildcon Llp, Snejyo Agro Llp and 2 more
Director 13 Apr 2021 5 Years 2 Months Current
Mahesh Purshottam Babani
Also directs: Babani Brothers Llp, Pee Vee Premises Llp, Privi Speciality Chemicals Limited and 3 more
Director 13 Apr 2021 5 Years 2 Months Current
Showing 6 of 7 current directors. View all directors

Financials of Privi Fine Sciences Private Limited FY 2025 filings available

Privi Fine Sciences Private Limited reported revenue of ₹52.15 Cr (up 546% YoY) for FY 2025. Profit growth despite declining revenue indicates effective cost management and margin discipline.

Revenue
₹52.15 Cr ▲ 546%
Profit
***** ▼ -1444%
EBITDA
***** ▼ -1210%
Metrics
*****
*****
*****
*****
*****
Revenue
Revenue from Operations
*****
*****
*****
*****
*****
Revenue Growth %
*****
*****
*****
*****
*****
Other Income
*****
*****
*****
*****
*****
Total Revenue
*****
*****
*****
*****
*****
Expenses
Total Expenses
*****
*****
*****
*****
*****
Raw Material Cost
*****
*****
*****
*****
*****
Change in Inventory FG
*****
*****
*****
*****
*****
Change in Inventory WIP
*****
*****
*****
*****
*****
Purchase of Traded Goods
*****
*****
*****
*****
*****
Employee Cost
*****
*****
*****
*****
*****
Managerial Remuneration
*****
*****
*****
*****
*****
Audit Fees
*****
*****
*****
*****
*****
Insurance
*****
*****
*****
*****
*****
Power & Fuel
*****
*****
*****
*****
*****
Interest
*****
*****
*****
*****
*****
Depreciation
*****
*****
*****
*****
*****
Other Expenses
*****
*****
*****
*****
*****
Profitability
EBITDA (Operating Profit)
*****
*****
*****
*****
*****
Operating Margin %
*****
*****
*****
*****
*****
Exceptional Items
*****
*****
*****
*****
*****
Extraordinary Items
*****
*****
*****
*****
*****
Profit Before Exceptional & Extraordinary Items
*****
*****
*****
*****
*****
Profit Before Tax
*****
*****
*****
*****
*****
Tax & Net Profit
Tax Expense
*****
*****
*****
*****
*****
Current Tax
*****
*****
*****
*****
*****
Deferred Tax
*****
*****
*****
*****
*****
Profit from Discontinued Operations
*****
*****
*****
*****
*****
Tax on Discontinued Operations
*****
*****
*****
*****
*****
Profit
*****
*****
*****
*****
*****
Net Margin %
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Shareholders' Funds
Total Shareholders' Funds
*****
*****
*****
*****
*****
Equity Capital
*****
*****
*****
*****
*****
Reserves & Surplus
*****
*****
*****
*****
*****
Money Against Warrants
*****
*****
*****
*****
*****
Other Equity
*****
*****
*****
*****
*****
Non-Current Liabilities
Total Non-Current Liabilities
*****
*****
*****
*****
*****
Long-Term Borrowings
*****
*****
*****
*****
*****
Deferred Tax Liabilities
*****
*****
*****
*****
*****
Other Non-Current Liabilities
*****
*****
*****
*****
*****
Long-Term Provisions
*****
*****
*****
*****
*****
Current Liabilities
Total Current Liabilities
*****
*****
*****
*****
*****
Short-Term Borrowings
*****
*****
*****
*****
*****
Trade Payables
*****
*****
*****
*****
*****
Other Current Liabilities
*****
*****
*****
*****
*****
Short-Term Provisions
*****
*****
*****
*****
*****
Total Equity & Liabilities
*****
*****
*****
*****
*****
Non-Current Assets
Non-Current Assets
*****
*****
*****
*****
*****
Tangible Assets
*****
*****
*****
*****
*****
Intangible Assets
*****
*****
*****
*****
*****
Capital WIP
*****
*****
*****
*****
*****
Intangibles Under Dev
*****
*****
*****
*****
*****
Investments
*****
*****
*****
*****
*****
Deferred Tax Assets
*****
*****
*****
*****
*****
LT Loans & Advances
*****
*****
*****
*****
*****
Other Non-Current Assets
*****
*****
*****
*****
*****
Current Assets
Current Assets
*****
*****
*****
*****
*****
Current Investments
*****
*****
*****
*****
*****
Inventories
*****
*****
*****
*****
*****
Trade Receivables
*****
*****
*****
*****
*****
Cash & Bank Balance
*****
*****
*****
*****
*****
ST Loans & Advances
*****
*****
*****
*****
*****
Other Current Assets
*****
*****
*****
*****
*****
Total Assets
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Cash from Operating Activities (CFO)
Profit Before Tax
*****
*****
*****
*****
*****
Non-Cash Adjustments
*****
*****
*****
*****
*****
+ Interest Expense
*****
*****
*****
*****
*****
+ Depreciation
*****
*****
*****
*****
*****
+/- Unrealized Forex
*****
*****
*****
*****
*****
- Dividend Income
*****
*****
*****
*****
*****
- Interest Income
*****
*****
*****
*****
*****
+/- Other Non-Cash Items
*****
*****
*****
*****
*****
Changes in Working Capital
*****
*****
*****
*****
*****
+/- Inventory
*****
*****
*****
*****
*****
+/- Debtors
*****
*****
*****
*****
*****
+/- Creditors
*****
*****
*****
*****
*****
Reconciliation Adjustments
*****
*****
*****
*****
*****
Cash Generated from Operations
*****
*****
*****
*****
*****
Income Taxes Paid
*****
*****
*****
*****
*****
Net CFO (Cash from Operations)
*****
*****
*****
*****
*****
Cash from Investing Activities (CFI)
Acquisitions & Disposals
*****
*****
*****
*****
*****
Disposal of Subsidiaries
*****
*****
*****
*****
*****
Acquisition of Subsidiaries
*****
*****
*****
*****
*****
Capex
*****
*****
*****
*****
*****
Purchase of Fixed Assets
*****
*****
*****
*****
*****
Sale of Fixed Assets
*****
*****
*****
*****
*****
Other Investing Cash Flows
*****
*****
*****
*****
*****
Net CFI (Cash from Investing)
*****
*****
*****
*****
*****
Cash from Financing Activities (CFF)
Equity Issuance
*****
*****
*****
*****
*****
Debt Raised
*****
*****
*****
*****
*****
Debt Repaid
*****
*****
*****
*****
*****
Dividends Paid
*****
*****
*****
*****
*****
Interest Paid
*****
*****
*****
*****
*****
Net CFF (Cash from Financing)
*****
*****
*****
*****
*****
Net Cash Position
Net Change in Cash (Pre-Forex)
*****
*****
*****
*****
*****
Closing Cash & Equivalents
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Liquidity
Current Ratio
*****
*****
*****
*****
*****
Quick Ratio
*****
*****
*****
*****
*****
Cash Ratio
*****
*****
*****
*****
*****
Efficiency
Inventory Days
*****
*****
*****
*****
*****
Debtor Days
*****
*****
*****
*****
*****
Creditor Days
*****
*****
*****
*****
*****
Cash Conversion Cycle
*****
*****
*****
*****
*****
Asset Turnover
*****
*****
*****
*****
*****
Profitability
Net Profit Margin %
*****
*****
*****
*****
*****
Operating Margin %
*****
*****
*****
*****
*****
ROE %
*****
*****
*****
*****
*****
ROCE %
*****
*****
*****
*****
*****
Net Worth Margin %
*****
*****
*****
*****
*****
Growth
Revenue Growth %
*****
*****
*****
*****
*****
Leverage
Equity Multiplier
*****
*****
*****
*****
*****
Debt / EBITDA
*****
*****
*****
*****
*****
Solvency
D/E Ratio
*****
*****
*****
*****
*****
ICR
*****
*****
*****
*****
*****

Consolidated Statements

Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.

Unlock Complete Financial History (FY 2015 – Latest)
Standalone & Consolidated - Income Statement, Balance Sheet, Cash Flow, Financial Ratios and Growth Trends with 10+ years of line-item data.
10+ years of data Line-item breakdown Balance Sheet detail Cash Flow analysis 20+ ratios & metrics Downloadable PDF

Shareholding Pattern of Privi Fine Sciences Private Limited

As of FY 2023, Privi Fine Sciences Private Limited's shareholding pattern shows 100.00% by promoters. The promoters hold a majority stake, indicating strong promoter control.

2025
YEAR
38.19% Promoters
25.22% DII (Domestic Institutional)
10.28% FII (Foreign Institutional)
25.89% Public
2.42% Others
Shareholding Trend
Year 2025
Promoters 33.19%
DII 23.22%
FII 18.28%
Public 22.89%
Others 2.42%

Charges & Borrowings of Privi Fine Sciences Private Limited

Open charges
₹100 Cr
Satisfied charges
₹0
Breakdown by lending institutions
Hdfc Bank Limited₹70.00 Cr
Others₹30.00 Cr
Latest charge details
DateLenderAmountStatus
14 Feb 2023 Others ₹15 Cr Open
14 Feb 2023 Hdfc Bank Limited ₹35 Cr Open
07 Dec 2022 Others ₹15 Cr Open
20 May 2022 Hdfc Bank Limited ₹35 Cr Open

Total charge records: 4 View all charges

Employees and EPFO Compliance at Privi Fine Sciences Private Limited

Privi Fine Sciences Private Limited has a workforce of 0 employees as of Apr 06, 2024.

Active EPFO establishments
1
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026

Employee Count & EPFO Data of Privi Fine Sciences Private Limited

Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.

Monthly employee headcount & PF contributions
EPFO establishment details & ECR filing status
Year-wise workforce analytics & attrition trends
PF exemption, coverage & compliance verification

GST Compliance of Privi Fine Sciences Private Limited

XX%
Compliant
GSTR-1
GSTR-3B
GSTR-9
MH
KA
UP
TN
TS

GSTIN & GST Filing Data of Privi Fine Sciences Private Limited

Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.

GSTIN registrations & state-wise presence
Filing compliance - GSTR-1, GSTR-3B, GSTR-9
HSN/SAC codes with goods & services details
Taxpayer type, jurisdiction & business constitution

Credit Ratings, Litigation & Regulatory Alerts for Privi Fine Sciences Private Limited

Credit rating
AAA
AA+
AA
AA-
! !
2015 2017 2019 2021 2023
Litigation
District Court 35
High Court 45
Supreme Court 0
NCLT / NCLAT 0
Pending
Disposed
Regulatory alerts
GSTIN Cancelled
Andhra Pradesh
GSTIN Cancelled
Telangana (on application)
EPFO Delay
12 months delay - Haryana
Violations via Directors
20 MCA + 19 Bank defaults

Credit Ratings, Legal Cases & Regulatory Alerts of Privi Fine Sciences Private Limited

Access complete credit rating history, litigation records, regulatory alerts, and compliance data.

Credit rating history across CARE, ICRA, Brickwork & India Ratings
Instrument-wise ratings, outlook & action timeline
Court-wise litigation (District, High Court, Supreme Court, NCLT)
Group company & common directorship litigation
Statutory compliance alerts (GSTIN, EPFO, ROC)
Director & company violations (MCA, SEBI, Banks, BSE/NSE)

MSME Payment Delays by Privi Fine Sciences Private Limited

MSME Payment Delays by Privi Fine Sciences Private Limited

Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.

Amounts outstanding to MSME suppliers
Delay periods & reasons for delayed payments
Half-yearly MSME-1 filing history
Vendor-payment behaviour as a counterparty risk signal

Subsidiaries & Group Companies of Privi Fine Sciences Private Limited

Subsidiaries & Group Companies of Privi Fine Sciences Private Limited

See the full corporate group - holding company, subsidiaries, associates and joint ventures of Privi Fine Sciences Private Limited with ownership details.

Holding & parent company details
Subsidiaries & step-down subsidiaries with % holding
Associates & joint ventures with partner details
Investments in other entities year-on-year

MCA Filings & Documents of Privi Fine Sciences Private Limited

MCA Filings & Documents of Privi Fine Sciences Private Limited

Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.

Incorporation documents, MoA & AoA
Annual returns (MGT-7) & financial statements (AOC-4)
Charge filings (CHG-1, CHG-4) & resolutions
Complete document index with filing dates

Recent Activity on Privi Fine Sciences Private Limited

Activity
15 Jul 2025
Privi Fine Sciences Private Limited last Annual general meeting of members was held on 15 Jul 2025 as per latest MCA records.
Activity
31 Mar 2025
Privi Fine Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai Ii.
Directors
12 Apr 2024
Arun Anant Newalkar was appointed as a CFO on 12 Apr 2024 & has been associated with this company since 2 years 2 months.
Directors
12 Apr 2024
Ramesh Vishanlal Kathuria was appointed as a Company Secretary on 12 Apr 2024 & has been associated with this company since 2 years 2 months.
Directors
01 Apr 2024
Sanjeev Gajanan Patil was appointed as a Whole-time director on 01 Apr 2024 & has been associated with this company since 2 years 3 months.
Directors
01 Apr 2024
Arun Anant Newalkar was appointed as a CFO on 01 Apr 2024 & has been associated with this company since 2 years 3 months.

Frequently Asked Questions about Privi Fine Sciences Private Limited

Privi Fine Sciences Private Limited is an active private limited company in the chemicals and materials sector based in Thane, Maharashtra, India. It was incorporated on 13 April 2021 (5+ years old) and is registered under CIN U24110MH2021PTC358857.

Privi Fine Sciences Private Limited reported revenue of ₹52.15 Cr for FY 2025 (up 546.00% YoY).

The current directors of Privi Fine Sciences Private Limited are:

The primary industry of Privi Fine Sciences Private Limited is chemicals and materials. The company specifically operates in industrial chemicals. The company is currently active in this sector.

Privi Fine Sciences Private Limited can be reached at the registered office: Ground Floor Privi House A – 71 Ttc, Thane Belapur Road Kopar Khairane Navi Mumbai, Maharashtra, India – 400710.

The authorised capital is ₹240 Cr, and the paid-up capital is ₹233.83 Cr.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available